Patent classifications
A61N5/0603
DEVICE AND METHOD FOR IMPROVED INDUCTION OF NOISE BY MEANS OF ELECTROMAGNETIC RADIATION
Provided herein is a device for improved induction of sound by electromagnetic radiation, comprising a carrier layer; a first substance having a reflective property with respect to electromagnetic radiation having a predetermined wavelength spectrum; and a second substance having an absorptive property with respect to electromagnetic radiation having said predetermined wavelength spectrum; wherein said first substance is disposed in a region between said carrier layer and said second substance. Furthermore, a corresponding method is provided.
Systems and methods for phototherapeutic modulation of nitric oxide
Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm.
DEVICE AND METHOD FOR ERADICATING PATHOGENS IN NASAL PASSAGES
A device for eradicating at least one pathogen in a nasal passage of a human or animal may include a housing configured to be inserted into the nasal passage, at least one radiation source, configured to emit radiation, coupled to the housing such that at least a portion of a radiation emitting surface, upon insertion of the housing into the nasal passage, faces at least a portion of nasal lining of the nasal passage, and an electrical circuit carried by the housing and electrically connected to the at least one radiation source, the electrical circuit including at least one circuit component for controlling the at least one radiation source to emit the radiation to irradiate the nasal passage, the emitted radiation having a frequency or range of frequencies at which the at least one pathogen in the nasal passage, when irradiated by the emitted radiation, is eradicated.
Oral treatment device
An oral treatment device that emits light onto surfaces of a user's teeth. In one aspect, the oral treatment device includes an intraoral mouthpiece. The mouthpiece comprises a lamp support structure comprising a lamp support surface and is formed of a first material. A flexible lamp is mounted to the lamp support surface so that a light emitting surface of the flexible lamp assumes a concave curvature, thereby forming a lamp assembly. A guard component is overmolded to the lamp assembly. In one embodiment, the oral treatment device may be a teeth whitening device.
Optical biopsy applicators for treatment planning, monitoring, and image-guided therapy
An in vivo optical biopsy applicator of the vaginal wall for treatment planning, monitoring, and imaging guided therapy is described herein. The applicator may include an imaging probe operatively coupled to a laser ablation device. The applicator allows for non-invasive optical tissue monitoring in order to define pre- and post menopausal parameters, pre- and post-treatment microscopic changes, and offers an objective scientific tool in order to compare currently available medical, non-medicated, and energy-based treatment protocols.
Aqueous solution for use in cleaning via irradiation by ultraviolet rays and/or near-ultraviolet visible light and/or light in 800-900 nm near-infrared region, dentifrice including said solution, dental treatment device, toothbrush, and tooth cleaning method
An aqueous solution for intraoral cleaning via irradiation with ultraviolet ray and/or near-ultraviolet visible ray and/or ray in an 800-900 nm near-infrared region is employed as the hydrogen peroxide aqueous solution, wherein a concentration of hydrogen peroxide is 1 w/v % to 7 w/v %, and a concentration of a hydrogen peroxide stabilizer is 81 ppm (mg/L) or less in the aqueous solution.
PUNCTURE DEVICE AND PHOTOTHERAPY METHOD
Provided is a puncture device includes: a needle tube; and a tube that is accommodated within the needle tube, is capable of accommodating an optical fiber, and is composed of a cylindrical optically-transparent material. The needle tube includes a tip member fixed to a distal end of the tube and having a blade surface at a tip thereof, and a base member that is disposed at a position where the base member covers a proximal end of the tube relative to the tip member and that is movable along a longitudinal axis of the needle tube. The base member advances to cause a distal end of the base member to abut on a proximal end of the tip member. The base member retracts to cause the distal end of the base member to move away from the proximal end of the tip member in a direction of the longitudinal axis.
OPTIMIZATION OF BPH TREATMENT USING LEP (LASER ENUCLEATION OF PROSTATE)
Apparatus for the treatment of a target tissue with a laser beam in which the target tissue is immersed in a liquid medium within a body lumen. The laser device is configured to provide one or more laser pulses which are configured by a controller to have an energy sufficient to form one or more vapor bubbles in the liquid medium at the distal delivery end of the fiber. The one or more pulses are configured by the controller to: first, cause a vapor bubble to be formed distally of the distal end portion of the endoscope and around the distal delivery end of the optical fiber; second, cause a second bubble to be formed distally of the first bubble; and, third, inflate the second bubble as the first bubble has begun to collapse to expand an amount sufficient to displace a substantial portion of the liquid medium from the space between the distal delivery end of the fiber and the target tissue.
Methods of treating skin cancer by administering a PD-1 inhibitor
The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer (e.g., skin cancer). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody). In certain embodiments, the skin cancer is cutaneous squamous cell carcinoma or basal cell carcinoma.
System and method of using endobronchial ultraviolet light therapy to treat patients infected with COVID-19 coronavirus, SARS, CoV-2
A catheter is disclosed for performing ultraviolet light therapy in a pulmonary system of a patient, which includes a catheter body having opposed proximal and distal end portions, a handle assembly operatively associated with the proximal end portion of the catheter body, an illumination assembly operatively associated with the distal end portion of the catheter body and including an LED light source for generating UVC radiation, wherein the illumination assembly includes a coupler connecting the LED light source with the distal end portion of the catheter body, and an elongated braided sleeve disposed within the catheter body, wherein the coupler is adapted to transfer heat from the illumination assembly to the braided sleeve, such that the braided sleeve serves as a heat sink for the illumination assembly.